PP
PAHC icon

Prospector Partners’s Phibro Animal Health PAHC Stock Holding History

Prospector Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-32,000
Closed -$1.06M – 115
2019
Q1 		$1.06M Buy
+32,000
New +$996K 0.16% 90

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Prospector Partners's PAHC Position: Q2 2019 in Review

Prospector Partners sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 32,000 shares — an estimated $1.06M sold.

Prospector Partners first reported a position in PAHC in Q1 2019 and held it in 1 quarter. The position peaked at $1.06M in Q1 2019. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Prospector Partners reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Prospector Partners sold 32,000 Phibro Animal Health shares in Q2 2019, an estimated $1.06M.
  • Prospector Partners first reported a position in Phibro Animal Health in Q1 2019 and held it in 1 quarter.
  • Prospector Partners's Phibro Animal Health position peaked at $1.06M in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Prospector Partners's 13F filing for Q2 2019, filed 14 Aug 2019.